Bias toward long gene misregulation in synaptic disorders can be an artefact of amplification-based methods
Several recent studies have suggested that genes that are longer than 100 kilobases are more likely to be misregulated in neurological diseases associated with synaptic dysfunction, such as autism and Rett syndrome. These length-dependent transcriptional changes are modest in Mecp2-mutant samples, but, given the low sensitivity of high-throughput transcriptome profiling technology, the statistical significance of these results needs to be re-evaluated. Here, we show that the apparent length-dependent trends previously observed in MeCP2 microarray and RNA-Sequencing datasets, particularly in genes with low fold-changes, disappeared after accounting for baseline variability estimated from randomized control samples. As we found no similar bias with NanoString technology, this long-gene bias seems to be particular to PCR amplification-based platforms. In contrast, authentic long gene effects, such as those caused by topoisomerase inhibition, can be detected even after adjustment for baseline variability. Accurate detection of length-dependent trends requires establishing a baseline from randomized control samples.\n\nHIGHLIGHTSO_LILength-dependent gene misregulation is not intrinsic to Mecp2 disruption.\nC_LIO_LITopoisomerase inhibition produces an authentic long gene bias.\nC_LIO_LIPCR amplification-based high-throughput datasets are biased toward long genes.\nC_LI